ConvaTec enters definitive agreement to acquire 180 Medical

NewsGuard 100/100 Score
Sep 1 2012

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has entered into a definitive agreement to acquire all of the capital stock of 180 Medical Holdings, Inc. ("180 Medical") for $321 million.  180 Medical is a leading U.S. provider of disposable, intermittent catheters and urologic medical supplies. 

The transaction is being funded primarily through incremental term debt under ConvaTec's credit agreement.  The transaction is subject to regulatory approval and customary closing conditions, and is expected to close late third quarter 2012.

SOURCE ConvaTec

Posted in: Business / Finance

Tags: , , , , ,

Comments (0)

Suggested Reading

Washington University School of Medicine joins collaboration to improve pediatric heart disease care
Digital remote monitoring technology in care homes reduces hospital admissions
Hospital sinks fuel antibiotic-resistant bacteria spread
Lurie Children's Hospital administers first gene therapy for Duchenne muscular dystrophy in Illinois
Female physicians may offer improved patient outcomes
How AI can make a more patient-friendly hospital discharge summary for patients
New comprehensive report on pediatric long COVID symptoms published
Study finds lack of preventative care for children with sickle cell anemia

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Fine particulate matter exposure linked to increased hospital admissions for major diseases